Healthcare provider profile · identity verified

Harrison A Kalodimos, MD

Family Practice · SHORELINE, WA · NPI 1487016689

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	488	140
Amlodipine Besylate	Amlodipine Besylate	425	113
Rosuvastatin Calcium	Rosuvastatin Calcium	365	105
Levothyroxine Sodium	Levothyroxine Sodium	319	84
Metformin Hcl Er	Metformin Hcl	253	65
Lisinopril	Lisinopril	233	68
Gabapentin	Gabapentin	218	68
Losartan Potassium	Losartan Potassium	214	59
Metoprolol Succinate	Metoprolol Succinate	194	60
Omeprazole	Omeprazole	175	46
Hydrochlorothiazide	Hydrochlorothiazide	146	42
Tamsulosin Hcl	Tamsulosin Hcl	145	50
Trazodone Hcl	Trazodone Hcl	123	35
Eliquis	Apixaban	116	30
Albuterol Sulfate Hfa	Albuterol Sulfate	101	28
Ozempic	Semaglutide	101	14
Simvastatin	Simvastatin	100	24
Metformin Hcl	Metformin Hcl	98	27
Pantoprazole Sodium	Pantoprazole Sodium	76	28
Sertraline Hcl	Sertraline Hcl	73	20
Benazepril Hcl	Benazepril Hcl	69	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	69	21
Jardiance	Empagliflozin	65	18
Alendronate Sodium	Alendronate Sodium	64	21
Fluoxetine Hcl	Fluoxetine Hcl	63	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	63	15
Pravastatin Sodium	Pravastatin Sodium	63	19
Meloxicam	Meloxicam	62	19
Venlafaxine Hcl Er	Venlafaxine Hcl	60	suppressed
Allopurinol	Allopurinol	59	16
Chlorthalidone	Chlorthalidone	58	17
Escitalopram Oxalate	Escitalopram Oxalate	57	19
Furosemide	Furosemide	57	18
Finasteride	Finasteride	56	17
Duloxetine Hcl	Duloxetine Hcl	53	14
Valsartan	Valsartan	51	13
Xarelto	Rivaroxaban	50	12
Lamotrigine	Lamotrigine	49	suppressed
Fluticasone Propionate	Fluticasone Propionate	45	17
Bupropion Xl	Bupropion Hcl	44	13
Doxazosin Mesylate	Doxazosin Mesylate	44	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	43	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	14
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	42	14
Oxycodone Hcl	Oxycodone Hcl	40	suppressed
Citalopram Hbr	Citalopram Hydrobromide	39	12
Trulicity	Dulaglutide	39	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	11
Quetiapine Fumarate	Quetiapine Fumarate	36	suppressed
Spironolactone	Spironolactone	35	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	35	suppressed
Baclofen	Baclofen	34	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	34	suppressed
Clopidogrel	Clopidogrel Bisulfate	34	suppressed
Montelukast Sodium	Montelukast Sodium	34	suppressed
Potassium Chloride	Potassium Chloride	33	suppressed
Testosterone Cypionate	Testosterone Cypionate	33	suppressed
Glimepiride	Glimepiride	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Donepezil Hcl	Donepezil Hcl	28	suppressed
Famotidine	Famotidine	28	11
Terazosin Hcl	Terazosin Hcl	28	suppressed
Carvedilol	Carvedilol	27	suppressed
Enalapril Maleate	Enalapril Maleate	27	suppressed
Farxiga	Dapagliflozin Propanediol	27	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Buprenorphine	Buprenorphine	25	suppressed
Ramipril	Ramipril	25	suppressed
Glipizide	Glipizide	24	suppressed
Lovastatin	Lovastatin	24	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	24	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Torsemide	Torsemide	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	20
Synthroid	Levothyroxine Sodium	23	suppressed
Valacyclovir	Valacyclovir Hcl	22	13
Telmisartan	Telmisartan	21	suppressed
Estradiol	Estradiol	20	suppressed
Atenolol	Atenolol	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Morphine Sulfate Er	Morphine Sulfate	19	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Spiriva Handihaler	Tiotropium Bromide	18	suppressed
Diazepam	Diazepam	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Ondansetron Odt	Ondansetron	17	13
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Clonazepam	Clonazepam	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Ketoconazole	Ketoconazole	13	11
Misoprostol	Misoprostol	13	suppressed
Nadolol	Nadolol	13	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Nystatin	Nystatin	12	suppressed
Prednisone	Prednisone	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	11	suppressed
Clonidine	Clonidine	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Nexium	Esomeprazole Magnesium	11	suppressed
Primidone	Primidone	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Topiramate	Topiramate	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error